Preventing excessive autophagy protects from the pathology of mtDNA mutations in Drosophila melanogaster.
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
Aberration of mitochondrial function is a shared feature of many human pathologies, characterised by changes in metabolic flux, cellular energetics, morphology, composition, and dynamics of the mitochondrial network. While some of these changes serve as compensatory mechanisms to maintain cellular homeostasis, their chronic activation can permanently affect cellular metabolism and signalling, ultimately impairing cell function. Here, we use a Drosophila melanogaster model expressing a proofreading-deficient mtDNA polymerase (POLγexo-) in a genetic screen to find genes that mitigate the harmful accumulation of mtDNA mutations. We identify critical pathways associated with nutrient sensing, insulin signalling, mitochondrial protein import, and autophagy that can rescue the lethal phenotype of the POLγexo- flies. Rescued flies, hemizygous for dilp1, atg2, tim14 or melted, normalise their autophagic flux and proteasome function and adapt their metabolism. Mutation frequencies remain high with the exception of melted-rescued flies, suggesting that melted may act early in development. Treating POLγexo- larvae with the autophagy activator rapamycin aggravates their lethal phenotype, highlighting that excessive autophagy can significantly contribute to the pathophysiology of mitochondrial diseases. Moreover, we show that the nucleation process of autophagy is a critical target for intervention.
Description
Acknowledgements: This study was supported by grants from the Swedish Research Council (VR2022-01287 (AWr) VR2023-07091(AWr), VR2019-01154(AWe)), the Novo Nordisk Foundation (NN0082202(AWr)), the Knut and Alice Wallenberg Foundation (KAW2019.0109 (AWr), KAW2020.0228(AWe)), the Region Stockholm (RS2022-0708 (A.Wr.)), and a Karolinska Institutet consolidator grant (2-190/2022 (A.Wr.)), the Swedish state under the ALF-agreement (FoUI-955096 (A.We.)). MM is supported by the Max-Planck Society for Advancement of Science. F.A.R. is an EMBO postdoctoral fellow (ALTF 399-2021 (FAR)). We thank Dirk Wischnewski from the Max-Planck Institute of Biochemistry for proteomic sample preparations. We thank Linda Partridge and Sebastian Grönke from the Max-Planck Institute for Biology of Ageing for donating the WDah strain. Fly stocks were obtained from the Bloomington Drosophila Stock Centre (NIH P40OD018537) and Vienna Drosophila Resource Centre.
Funder: Max-Planck-Gesellschaft (Max Planck Society); doi: https://doi.org/10.13039/501100004189
Funder: the Region Stockholm RS2022-0708 and FoUI-955096
Journal Title
Conference Name
Journal ISSN
2041-1723
Volume Title
Publisher
Publisher DOI
Rights and licensing
Sponsorship
Novo Nordisk Fonden (Novo Nordisk Foundation) (NN0082202)
Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) (KAW2019.0109, KAW2020.0228)
Karolinska Institutet (Karolinska Institute) (2-190/2022)
European Molecular Biology Organization (EMBO) (ALTF 399-2021)

